Page last updated: 2024-09-03

imatinib mesylate and Mastocytoma, Skin

imatinib mesylate has been researched along with Mastocytoma, Skin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonkobara, M; Ishii, N; Isotani, M; Ito, K; Kobayashi, M; Kuroki, S; Ono, K; Sasaki, Y; Sugisaki, O; Washizu, T; Yamada, O	1
Bertani, C; Magi, GE; Mari, S; Marini, C; Ogilvie, G; Renzoni, G; Rossi, G	1

Other Studies

2 other study(ies) available for imatinib mesylate and Mastocytoma, Skin

Article	Year
Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation. Veterinary immunology and immunopathology, 2011, Jul-15, Volume: 142, Issue:1-2 Topics: Animals; Antineoplastic Agents; Benzamides; Dog Diseases; Dogs; Imatinib Mesylate; Male; Mastocytoma, Skin; Phosphorylation; Piperazines; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-kit; Pyrimidines; Treatment Outcome	2011
Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis. Veterinary research communications, 2013, Volume: 37, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Biopsy; Caspase 3; Dog Diseases; Dogs; Exons; Imatinib Mesylate; Immunohistochemistry; In Situ Nick-End Labeling; Ki-67 Antigen; Male; Mast Cells; Mastocytoma, Skin; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-kit; Pyrimidines	2013

Article

Year

Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation.

Veterinary immunology and immunopathology, 2011, Jul-15, Volume: 142, Issue:1-2

Topics: Animals; Antineoplastic Agents; Benzamides; Dog Diseases; Dogs; Imatinib Mesylate; Male; Mastocytoma, Skin; Phosphorylation; Piperazines; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-kit; Pyrimidines; Treatment Outcome

2011

Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis.

Veterinary research communications, 2013, Volume: 37, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Biopsy; Caspase 3; Dog Diseases; Dogs; Exons; Imatinib Mesylate; Immunohistochemistry; In Situ Nick-End Labeling; Ki-67 Antigen; Male; Mast Cells; Mastocytoma, Skin; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-kit; Pyrimidines

2013